作者：
Ming,Shi [1]
;
Jiaojiao,Wang [2]
;
Hongming,Huang [3]
;
Dan,Liu [1]
;
Hai,Cheng [4]
;
Xu,Wang [5]
;
Wei,Chen [6]
;
Zhiling,Yan [2]
;
Wei,Sang [1]
;
Kunming,Qi [5]
;
Depeng,Li [6]
;
Feng,Zhu [2]
;
Zhenyu,Li [2]
;
Jianlin,Qiao [2]
;
Qingyun,Wu [2]
;
Lingyu,Zeng [2]
;
Xiaoming,Fei [2]
;
Weiying,Gu [2]
;
Yuqing,Miao [4]
;
Kailin,Xu [4]
;
Junnian,Zheng [4]
;
Jiang,Cao [7]
作者单位：
Cancer Institute, Xuzhou Medical University, Xuzhou, 221002, China.
[1]
Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
[2]
Department of Hematology, The Affiliated Hospital of Nantong University, Nantong, 226000, China.
[3]
Jiangsu Bone Marrow Stem Cell Institute, Xuzhou, 221002, China.
[4]
Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
[5]
Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, 221002, China.
[6]
Department of Hematology, The Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
[7]
Department of Hematology, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, 213000, China.
[8]
Department of Hematology, Yancheng No. People's Hospital, Yancheng, 224006, China.
[9]
Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China. lihmd@163.com.
[10]
Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China. jnzheng@xzhmu.edu.cn.
[11]
Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, 221002, China. jnzheng@xzhmu.edu.cn.
[12]
Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China. zimu05067@163.com.
[13]
DOI
10.1038/s41467-024-47801-8
PMID
38643278
发布时间
2024-05-22
换一批
换一批
